Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
79 studies found for:    Open Studies | "Mesothelioma"
Show Display Options
Rank Status Study
1 Recruiting Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Recurrent Malignant Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter;   Other: laboratory biomarker analysis;   Procedure: single photon emission computed tomography;   Procedure: computed tomography
2 Recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: cisplatin;   Drug: cediranib maleate;   Other: placebo
3 Not yet recruiting Alisertib in Malignant Mesothelioma
Conditions: Lung Cancer;   Mesothelioma
Intervention: Drug: Alisertib
4 Recruiting Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
5 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
6 Not yet recruiting Vinorelbine in Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Vinorelbine;   Other: Active Symptom Control
7 Unknown  Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
8 Unknown  Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer;   Mesothelioma
Intervention:
9 Recruiting Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
10 Recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Drug: SS1P
11 Recruiting Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Condition: Mesothelioma
Intervention: Drug: Zometa (zoledronic acid)
12 Recruiting Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Condition: Malignant Mesothelioma
Interventions: Drug: pemetrexed disodium;   Other: clinical observation
13 Not yet recruiting Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Condition: Mesothelioma
Intervention: Drug: Oshadi D and Oshadi R
14 Recruiting PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Radiation: Prophylactic Irradiation of Tracts (PIT)
15 Unknown  Axitinib in Malignant Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Biological: axitinib;   Drug: chemotherapy
16 Recruiting The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: Tremelimumab
17 Unknown  Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: study of high risk factors
18 Recruiting ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Trabectedin
19 Recruiting Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: VS-6063
20 Recruiting Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Genetic: Adoptive Transfer of re-directed T cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years